Cargando…

A de novo monoclonal immunoglobulin deposition disease in a kidney transplant recipient: a case report

INTRODUCTION: Myeloma following kidney transplantation is a rare entity. It can be divided into two groups: relapse of a previous myeloma and de novo myeloma. Some of these myelomas can be complicated by a monoclonal immunoglobulin deposition disease, which is even less common. Less than ten cases o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Savenkoff, Benjamin, Aubertin, Perrine, Ladriere, Marc, Hulin, Cyril, Champigneulle, Jacqueline, Frimat, Luc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090629/ https://www.ncbi.nlm.nih.gov/pubmed/24942882 http://dx.doi.org/10.1186/1752-1947-8-205

Ejemplares similares

Impact of reduced exposure to calcineurin inhibitors on the development of de novo DSA: a cohort of non-immunized first kidney graft recipients between 2007 and 2014
por: Girerd, S., et al.
Publicado: (2018)

An Early Immediate Early Protein IE-1–Specific T-Cell Polyfunctionality Is Associated With a Better Control of Cytomegalovirus Reactivation in Kidney Transplantation
por: Dekeyser, Manon, et al.
Publicado: (2017)

Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study
por: Matignon, Marie, et al.
Publicado: (2017)

An update of proliferative glomerulonephritis with monoclonal immunoglobulin deposits
por: Li, Manna, et al.
Publicado: (2021)

A Review on the Diagnosis and Treatment of Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits
por: Lin, Li, et al.
Publicado: (2022)

The Role of Kidney Transplantation in Monoclonal Ig Deposition Disease
por: Angel-Korman, Avital, et al.
Publicado: (2020)

De Novo Cytomegalovirus Colitis in a Donor-Seronegative/Recipient-Seronegative Kidney Transplant Recipient
por: Sulaiman, Zoheb I, et al.
Publicado: (2023)

De Novo Belatacept in a Kidney-After-Heart Transplant Recipient
por: Schenk, Austin D., et al.
Publicado: (2019)

Proliferative glomerulonephritis with monoclonal immunoglobulin deposition disease: The utility of routine staining with immunoglobulin light chains
por: Gowda, K. K., et al.
Publicado: (2015)

The Evolution of Monoclonal Gammopathy of Undetermined Significance in Kidney Transplant Recipients
por: Gagnon, Marie-France, et al.
Publicado: (2019)

Daratumumab in Patients With Bortezomib-Refractory Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits
por: Almaani, Salem, et al.
Publicado: (2021)

Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin Deposits
por: Zand, Ladan, et al.
Publicado: (2021)

Clinicopathological manifestations of coexistent monoclonal immunoglobulin deposition disease and immunotactoid glomerulopathy
por: Wang, Yina, et al.
Publicado: (2022)

Hypercalcemia is common during Pneumocystis pneumonia in kidney transplant recipients
por: Hamroun, Aghilès, et al.
Publicado: (2019)

Proliferative glomerulonephritis with monoclonal immunoglobulin deposits triggered by COVID-19: a case report
por: Shieh, Michelle, et al.
Publicado: (2022)

True effect of monoclonal antibody for COVID-19 in kidney transplant recipients
por: Khatri, Akshay, et al.
Publicado: (2022)

Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: Successful treatment for new and rare entity
por: Jerbi, Mouna, et al.
Publicado: (2020)

Efficacy of Immunomodulatory Drugs in Combination With Dexamethasone in Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits
por: Zhou, Houan, et al.
Publicado: (2022)

Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients
por: Pilon, Caroline, et al.
Publicado: (2020)

Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits in a young woman: A case report
por: Xu, Zi-Gan, et al.
Publicado: (2021)

Clinical significance of serum galactose-deficient immunoglobulin A1 for detection of recurrent immunoglobulin A nephropathy in kidney transplant recipients
por: Park, Woo Yeong, et al.
Publicado: (2021)

Association between Long-Term Change in Arterial Stiffness and Cardiovascular Outcomes in Kidney Transplant Recipients: Insights from the TRANSARTE Study
por: Salib, Madonna, et al.
Publicado: (2022)

Proliferative glomerulonephritis with monoclonal IgG deposits; an unusual cause of de novo disease in kidney allograft
por: Hussain, Sabiha M, et al.
Publicado: (2017)

Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection
por: Chavarot, Nathalie, et al.
Publicado: (2022)

Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Costimulation pathway blockade in kidney transplant recipients with de-novo rheumatoid arthritis
por: Sheta, Mohamed, et al.
Publicado: (2017)

Nephrotic Syndrome Secondary to Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits of Lambda Light Chain
por: Yun, Seongseok, et al.
Publicado: (2014)

Proliferative Glomerulonephritis with Monoclonal Immunoglobulin G Lambda Deposits: Report of the First Pediatric Case
por: Torrealba, Jose, et al.
Publicado: (2018)

Randall-Type Monoclonal Immunoglobulin Deposition Disease: New Insights into the Pathogenesis, Diagnosis and Management
por: Cohen, Camille, et al.
Publicado: (2021)

Renal Diseases Associated with Hematologic Malignancies and Thymoma in the Absence of Renal Monoclonal Immunoglobulin Deposits
por: Morel, Antoine, et al.
Publicado: (2021)

Post-transplant de-novo renal phospholipidosis in a kidney transplant recipient: Fabry disease or something else?
por: Naseer, Muhammad Saad, et al.
Publicado: (2020)

Prognostic value for long-term graft survival of estimated glomerular filtration rate and proteinuria quantified at 3 months after kidney transplantation
por: Mottola, Clément, et al.
Publicado: (2020)

AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis
por: Manabe, Shun, et al.
Publicado: (2018)

Relapsing and Remitting Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits in Association With Infection and Vaccination: A Case Report
por: Moubarak, Simon, et al.
Publicado: (2022)

CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients
por: Schulz, Uwe, et al.
Publicado: (2016)

39. Anti-Spike Monoclonal Antibody Therapy for Kidney Transplant Recipients with COVID-19
por: Hardesty, Anna, et al.
Publicado: (2021)

In Reply to ‘Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations’
por: Fernandes, Guillaume, et al.
Publicado: (2022)

Conversion to mammalian target of rapamycin inhibitors in kidney transplant recipients with de novo cancers
por: Cheung, Chi Yuen, et al.
Publicado: (2017)

Glomerulonephritis with non-Randall-type, non-cryoglobulinaemic monoclonal immunoglobulin G deposits (PGNMID and ITG)
por: Fourdinier, Ophélie, et al.
Publicado: (2022)

Acute renal failure in a patient with PR3-ANCA and monoclonal immunoglobulin deposition disease: Case report
por: Cassol, Clarissa A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nruuct7hrmuro7g52mldsl8olg